Brief: Neubase Therapeutics Board Approved A Change In Co's Fiscal Year
24/04/2023 23:08
April 24 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS INC - ON APRIL 21, BOARD APPROVED A
CHANGE
IN CO'S FISCAL YEAR
* NEUBASE THERAPEUTICS INC - CHANGE IN FISCAL YEAR FROM 12
MONTHS
BEGINNING OCT 1 AND ENDING SEPT 30 TO 12 MONTHS BEGINNING JAN 1
AND ENDING DEC 31
* NEUBASE THERAPEUTICS INC - CHANGE IN COMPANY'S FISCAL
YEAR WILL
BE EFFECTIVE FOR YEAR ENDING DECEMBER 31, 2023
Source text for Eikon: ID:
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet